Overview

The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study

Status:
Not yet recruiting

Trial end date:
2028-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess and compare GI toxicity from RT between subjects who receive therapeutic SCFA and those who receive placebo, in hopes of identifying a safe, low-cost therapeutic to reduce GI toxicity from therapeutic or environmental radiation.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

UNC Lineberger Comprehensive Cancer Center

Treatments:

Butyric Acid